BRPI0410041A - métodos para tratamento de dor de cabeça de sinusite - Google Patents
métodos para tratamento de dor de cabeça de sinusiteInfo
- Publication number
- BRPI0410041A BRPI0410041A BRPI0410041-7A BRPI0410041A BRPI0410041A BR PI0410041 A BRPI0410041 A BR PI0410041A BR PI0410041 A BRPI0410041 A BR PI0410041A BR PI0410041 A BRPI0410041 A BR PI0410041A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- sinus headache
- botulinum toxin
- sinus
- headache treatment
- Prior art date
Links
- 206010040744 Sinus headache Diseases 0.000 title abstract 3
- 108030001720 Bontoxilysin Proteins 0.000 abstract 4
- 229940053031 botulinum toxin Drugs 0.000 abstract 4
- 206010019233 Headaches Diseases 0.000 abstract 1
- 231100000869 headache Toxicity 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
"MéTODOS PARA TRATAMENTO DE DOR DE CABEçA DE SINUSITE". A presente invenção refere-se a uma dor de cabeça de sinusite que pode ser tratada por administração de uma toxina botulínica a um paciente. A toxina botulínica pode ser toxina botulínica do tipo A e a toxina botulínica pode ser administrada a uma, ou às vizinhanças de uma, membrana de seio de um paciente com dor de cabeça de sinusite.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/429,069 US6838434B2 (en) | 2003-05-02 | 2003-05-02 | Methods for treating sinus headache |
| PCT/US2004/013480 WO2004098714A1 (en) | 2003-05-02 | 2004-04-30 | Methods for treating sinus headache |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0410041A true BRPI0410041A (pt) | 2006-04-25 |
Family
ID=33310536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0410041-7A BRPI0410041A (pt) | 2003-05-02 | 2004-04-30 | métodos para tratamento de dor de cabeça de sinusite |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6838434B2 (pt) |
| EP (1) | EP1620182B1 (pt) |
| JP (2) | JP4814086B2 (pt) |
| KR (1) | KR101057508B1 (pt) |
| CN (1) | CN1780664A (pt) |
| AR (1) | AR044146A1 (pt) |
| AT (1) | ATE446792T1 (pt) |
| AU (1) | AU2004235743B2 (pt) |
| BR (1) | BRPI0410041A (pt) |
| CA (1) | CA2524379C (pt) |
| CL (1) | CL2004000897A1 (pt) |
| DE (1) | DE602004023829D1 (pt) |
| DK (1) | DK1620182T3 (pt) |
| ES (1) | ES2333017T3 (pt) |
| IL (1) | IL171607A (pt) |
| MX (1) | MXPA05011470A (pt) |
| PL (1) | PL378982A1 (pt) |
| TW (1) | TWI323663B (pt) |
| WO (1) | WO2004098714A1 (pt) |
| ZA (1) | ZA200508287B (pt) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974578B1 (en) * | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
| NZ541779A (en) * | 2003-03-06 | 2008-01-31 | Botulinum Toxin Res Ass Inc | Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| US6838434B2 (en) * | 2003-05-02 | 2005-01-04 | Allergan, Inc. | Methods for treating sinus headache |
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| EP1644004A4 (en) * | 2003-06-20 | 2010-10-06 | Ronald Aung-Din | LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS |
| US8734810B2 (en) * | 2003-10-29 | 2014-05-27 | Allergan, Inc. | Botulinum toxin treatments of neurological and neuropsychiatric disorders |
| US20050191321A1 (en) * | 2004-02-26 | 2005-09-01 | Allergan, Inc. | Methods for treating headache |
| US20100266638A1 (en) | 2004-02-26 | 2010-10-21 | Allergan, Inc. | Headache treatment method |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US7514088B2 (en) * | 2005-03-15 | 2009-04-07 | Allergan, Inc. | Multivalent Clostridial toxin derivatives and methods of their use |
| US7922983B2 (en) * | 2005-07-28 | 2011-04-12 | Kimberly-Clark Worldwide, Inc. | Sterilization wrap with additional strength sheet |
| US7811584B2 (en) | 2004-06-30 | 2010-10-12 | Allergan, Inc. | Multivalent clostridial toxins |
| US20060024331A1 (en) * | 2004-08-02 | 2006-02-02 | Ester Fernandez-Salas | Toxin compounds with enhanced membrane translocation characteristics |
| EP1982997B1 (en) | 2004-09-01 | 2012-08-08 | Allergan, Inc. | Degradable clostridial toxins |
| US7897147B2 (en) | 2004-10-20 | 2011-03-01 | Allergan, Inc. | Treatment of premenstrual disorders |
| US7749515B2 (en) * | 2005-02-01 | 2010-07-06 | Allergan, Inc. | Targeted delivery of botulinum toxin to the sphenopalatine ganglion |
| US7655244B2 (en) | 2005-02-01 | 2010-02-02 | Allergan, Inc. | Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| EP1861419B1 (en) | 2005-03-15 | 2011-06-29 | Allergan, Inc. | Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| US8105611B2 (en) * | 2005-06-17 | 2012-01-31 | Allergan, Inc. | Treatment of autoimmune disorder with a neurotoxin |
| US10052465B2 (en) | 2005-07-22 | 2018-08-21 | The Foundry, Llc | Methods and systems for toxin delivery to the nasal cavity |
| US12433837B2 (en) | 2005-07-22 | 2025-10-07 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
| US9511210B2 (en) * | 2006-05-19 | 2016-12-06 | The Foundry, Llc | Apparatus for toxin delivery to the nasal cavity |
| JP5826450B2 (ja) | 2005-07-22 | 2015-12-02 | ザ ファウンドリー, エルエルシー | 治療薬の送達のためのシステムおよび方法 |
| US7910116B2 (en) * | 2005-08-24 | 2011-03-22 | Allergan, Inc. | Use of a botulinum toxin to improve gastric emptying and/or to treat GERD |
| US7824694B2 (en) * | 2006-01-12 | 2010-11-02 | Allergan, Inc. | Methods for enhancing therapeutic effects of a neurotoxin |
| AR061669A1 (es) | 2006-06-29 | 2008-09-10 | Merz Pharma Gmbh & Co Kgaa | Aplicacion de alta frecuencia de terapia con toxina botulinica |
| US10792344B2 (en) | 2006-06-29 | 2020-10-06 | Merz Pharma Gmbh & Co. Kgaa | High frequency application of botulinum toxin therapy |
| US9061025B2 (en) * | 2006-08-31 | 2015-06-23 | Allergan, Inc. | Methods for selecting headache patients responsive to botulinum toxin therapy |
| DE102007038015A1 (de) * | 2007-08-10 | 2009-02-19 | Hefter, Harald, Prof. Dr. med. Dr. rer. nat. | Verwendung eines Neurotoxins |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| US8470337B2 (en) * | 2008-03-13 | 2013-06-25 | Allergan, Inc. | Therapeutic treatments using botulinum neurotoxin |
| US8617571B2 (en) | 2008-04-03 | 2013-12-31 | Allergan, Inc. | Suture line administration technique using botulinum toxin |
| EP2320821B2 (en) | 2008-05-09 | 2020-12-30 | Nuvaira, Inc. | Systems for treating a bronchial tree |
| ES2356883B1 (es) * | 2008-07-24 | 2012-02-22 | Bcn Peptides, S.A. | Composición para el tratamiento del dolor y/o la inflamación. |
| CN104856757B (zh) | 2009-10-27 | 2017-06-23 | 赫莱拉公司 | 具有可冷却的能量发射组件的递送装置 |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| EP4111995A1 (en) | 2009-11-11 | 2023-01-04 | Nuvaira, Inc. | Device for treating tissue and controlling stenosis |
| WO2011084507A1 (en) * | 2009-12-15 | 2011-07-14 | Ira Sanders | Treatment of nasal and sinus disorders |
| US20120244188A1 (en) * | 2011-03-25 | 2012-09-27 | Allergan, Inc. | Treatment of Sensory Disturbance Disorders |
| US20120251574A1 (en) * | 2011-03-28 | 2012-10-04 | Allergan, Inc. | Endopeptidase and Neurotoxin Combination Treatment of Multiple Medical Conditions |
| ES2424294B1 (es) | 2012-03-22 | 2014-07-21 | Lipotec, S.A. | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas |
| EP2649983A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (II) |
| ES2660901T3 (es) | 2012-04-13 | 2018-03-26 | Lubrizol Advanced Materials, Inc. | Compuestos que inhiben la exocitosis neuronal (II) |
| EP2649984A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
| EP2649985A1 (en) | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis (III) |
| US9005628B2 (en) | 2012-10-04 | 2015-04-14 | Dublin City University | Biotherapy for pain |
| WO2014066916A2 (en) | 2012-10-28 | 2014-05-01 | Revance Therapeutics, Inc. | Compositions and methods for safe treatment of rhinitis |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| EP2976060B1 (en) | 2013-03-22 | 2016-10-26 | Lipotec, S.A. | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails |
| GB201312317D0 (en) | 2013-07-09 | 2013-08-21 | Syntaxin Ltd | Cationic neurotoxins |
| US10149893B2 (en) | 2013-09-24 | 2018-12-11 | Allergan, Inc. | Methods for modifying progression of osteoarthritis |
| US9216210B2 (en) | 2013-12-23 | 2015-12-22 | Dublin City University | Multiprotease therapeutics for chronic pain |
| US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
| WO2016110662A1 (en) | 2015-01-09 | 2016-07-14 | Ipsen Bioinnovation Limited | Cationic neurotoxins |
| GB201517450D0 (en) | 2015-10-02 | 2015-11-18 | Ipsen Biopharm Ltd | Method |
| GB201607901D0 (en) | 2016-05-05 | 2016-06-22 | Ipsen Biopharm Ltd | Chimeric neurotoxins |
| EP3263710A1 (en) | 2016-07-01 | 2018-01-03 | Ipsen Biopharm Limited | Production of activated clostridial neurotoxins |
| CN109790204A (zh) | 2016-09-29 | 2019-05-21 | 益普生生物制药有限公司 | 杂合神经毒素 |
| WO2019162696A1 (en) | 2018-02-26 | 2019-08-29 | Ipsen Biopharm Limited | Use of ultrasound to guide injection of non-cytotoxic protease |
| US11752201B2 (en) | 2019-01-07 | 2023-09-12 | Babak Azizzadeh | Treatment of stress disorders, including post-traumatic stress disorder, using acetylcholine release inhibiting neurotoxic proteins to reduce stress levels |
| GB202103372D0 (en) | 2021-03-11 | 2021-04-28 | Ipsen Biopharm Ltd | Modified clostridial neurotoxins |
| KR102941554B1 (ko) * | 2021-10-22 | 2026-03-19 | 비피메드(주) | 보툴리눔 유래 펩타이드를 포함하는 탈모개선용 조성물 |
| US20240408184A1 (en) * | 2021-10-25 | 2024-12-12 | Bpmed Co., Ltd. | Composition comprising botulinum-derived peptide for pain relief |
| EP4593873A1 (en) | 2022-09-30 | 2025-08-06 | Ipsen Biopharm Limited | Clostridial neurotoxin for use in a treatment of bladder pain syndrome |
| GB202318884D0 (en) | 2023-12-11 | 2024-01-24 | Ipsen Biopharm Ltd | Formulation |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9120306D0 (en) * | 1991-09-24 | 1991-11-06 | Graham Herbert K | Method and compositions for the treatment of cerebral palsy |
| US5437291A (en) | 1993-08-26 | 1995-08-01 | Univ Johns Hopkins | Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction |
| US6974578B1 (en) | 1993-12-28 | 2005-12-13 | Allergan, Inc. | Method for treating secretions and glands using botulinum toxin |
| US5766605A (en) | 1994-04-15 | 1998-06-16 | Mount Sinai School Of Medicine Of The City University Of New York | Treatment of autonomic nerve dysfunction with botulinum toxin |
| US5670484A (en) | 1994-05-09 | 1997-09-23 | Binder; William J. | Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders |
| ATE215832T1 (de) * | 1994-05-09 | 2002-04-15 | William J Binder | Botulinumtoxin zur reduktion von migraine - kopfschmerzen |
| GB9508204D0 (en) | 1995-04-21 | 1995-06-07 | Speywood Lab Ltd | A novel agent able to modify peripheral afferent function |
| ATE320815T1 (de) * | 1997-07-15 | 2006-04-15 | Univ Colorado | Verwendung einer neurotoxintherapie zur behandlung von prostata erkrankungen |
| US6063768A (en) | 1997-09-04 | 2000-05-16 | First; Eric R. | Application of botulinum toxin to the management of neurogenic inflammatory disorders |
| TW574036B (en) * | 1998-09-11 | 2004-02-01 | Elan Pharm Inc | Stable liquid compositions of botulinum toxin |
| DE19925739A1 (de) * | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
| US6113915A (en) | 1999-10-12 | 2000-09-05 | Allergan Sales, Inc. | Methods for treating pain |
| US6265379B1 (en) * | 1999-10-13 | 2001-07-24 | Allergan Sales, Inc. | Method for treating otic disorders |
| US6139845A (en) * | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
| US6429189B1 (en) * | 1999-12-10 | 2002-08-06 | Botulinum Toxin Research Associates, Inc. | Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases |
| US6143306A (en) * | 2000-01-11 | 2000-11-07 | Allergan Sales, Inc. | Methods for treating pancreatic disorders |
| US6358513B1 (en) * | 2000-02-15 | 2002-03-19 | Allergan Sales, Inc. | Method for treating Hashimoto's thyroiditis |
| US6319506B1 (en) * | 2000-02-22 | 2001-11-20 | Allergan, Sales, Inc. | Method for treating hypercalcemia |
| US6464986B1 (en) * | 2000-04-14 | 2002-10-15 | Allegan Sales, Inc. | Method for treating pain by peripheral administration of a neurotoxin |
| US6299893B1 (en) * | 2000-04-17 | 2001-10-09 | Marvin Schwartz | Method to reduce hair loss and stimulate hair regrowth |
| US6306423B1 (en) * | 2000-06-02 | 2001-10-23 | Allergan Sales, Inc. | Neurotoxin implant |
| US6306403B1 (en) * | 2000-06-14 | 2001-10-23 | Allergan Sales, Inc. | Method for treating parkinson's disease with a botulinum toxin |
| JP3860403B2 (ja) | 2000-09-25 | 2006-12-20 | 株式会社東芝 | 半導体メモリ装置 |
| US6423319B1 (en) * | 2000-10-04 | 2002-07-23 | Allergan Sales, Inc. | Methods for treating muscle injuries |
| US20020192239A1 (en) | 2001-01-09 | 2002-12-19 | Borodic Gary E. | Use of botulinum toxin for the treatment of chronic facial pain |
| WO2003000193A2 (en) | 2001-06-21 | 2003-01-03 | Surromed, Inc. | Covalent coupling of botulinum toxin with polyethylene glycol |
| CA2369810C (en) * | 2002-01-30 | 2007-08-07 | 1474791 Ontario Limited | Method of treating pain |
| US7670608B2 (en) * | 2003-03-06 | 2010-03-02 | Botulinum Toxin Research Associates, Inc. | Selection of patients with increased responsiveness to botulinum toxin |
| NZ541779A (en) * | 2003-03-06 | 2008-01-31 | Botulinum Toxin Res Ass Inc | Treatment of sinusitis related chronic facial pain and headache with botulinum toxin |
| US6838434B2 (en) * | 2003-05-02 | 2005-01-04 | Allergan, Inc. | Methods for treating sinus headache |
-
2003
- 2003-05-02 US US10/429,069 patent/US6838434B2/en not_active Expired - Lifetime
-
2004
- 2004-04-14 TW TW093110314A patent/TWI323663B/zh not_active IP Right Cessation
- 2004-04-28 CL CL200400897A patent/CL2004000897A1/es unknown
- 2004-04-30 JP JP2006514187A patent/JP4814086B2/ja not_active Expired - Fee Related
- 2004-04-30 KR KR1020057020797A patent/KR101057508B1/ko not_active Expired - Fee Related
- 2004-04-30 WO PCT/US2004/013480 patent/WO2004098714A1/en not_active Ceased
- 2004-04-30 EP EP04751060A patent/EP1620182B1/en not_active Expired - Lifetime
- 2004-04-30 BR BRPI0410041-7A patent/BRPI0410041A/pt not_active IP Right Cessation
- 2004-04-30 ES ES04751060T patent/ES2333017T3/es not_active Expired - Lifetime
- 2004-04-30 CN CNA2004800116765A patent/CN1780664A/zh active Pending
- 2004-04-30 AU AU2004235743A patent/AU2004235743B2/en not_active Ceased
- 2004-04-30 PL PL378982A patent/PL378982A1/pl not_active Application Discontinuation
- 2004-04-30 AT AT04751060T patent/ATE446792T1/de active
- 2004-04-30 AR ARP040101485A patent/AR044146A1/es not_active Application Discontinuation
- 2004-04-30 DK DK04751060.7T patent/DK1620182T3/da active
- 2004-04-30 DE DE602004023829T patent/DE602004023829D1/de not_active Expired - Lifetime
- 2004-04-30 MX MXPA05011470A patent/MXPA05011470A/es active IP Right Grant
- 2004-04-30 CA CA2524379A patent/CA2524379C/en not_active Expired - Fee Related
- 2004-11-19 US US10/994,147 patent/US20050152924A1/en not_active Abandoned
-
2005
- 2005-10-13 ZA ZA200508287A patent/ZA200508287B/xx unknown
- 2005-10-27 IL IL171607A patent/IL171607A/en active IP Right Grant
-
2011
- 2011-04-07 JP JP2011084968A patent/JP2011137042A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK1620182T3 (da) | 2010-03-01 |
| US6838434B2 (en) | 2005-01-04 |
| TW200503751A (en) | 2005-02-01 |
| CL2004000897A1 (es) | 2005-01-07 |
| PL378982A1 (pl) | 2006-06-26 |
| ATE446792T1 (de) | 2009-11-15 |
| ZA200508287B (en) | 2007-03-28 |
| DE602004023829D1 (de) | 2009-12-10 |
| WO2004098714A1 (en) | 2004-11-18 |
| CA2524379A1 (en) | 2004-11-18 |
| US20040219172A1 (en) | 2004-11-04 |
| KR20060006956A (ko) | 2006-01-20 |
| KR101057508B1 (ko) | 2011-08-17 |
| CA2524379C (en) | 2015-03-31 |
| TWI323663B (en) | 2010-04-21 |
| EP1620182B1 (en) | 2009-10-28 |
| HK1087957A1 (en) | 2006-10-27 |
| MXPA05011470A (es) | 2005-12-12 |
| EP1620182A1 (en) | 2006-02-01 |
| AR044146A1 (es) | 2005-08-24 |
| ES2333017T3 (es) | 2010-02-16 |
| AU2004235743A1 (en) | 2004-11-18 |
| AU2004235743B2 (en) | 2009-10-01 |
| US20050152924A1 (en) | 2005-07-14 |
| JP2006525353A (ja) | 2006-11-09 |
| CN1780664A (zh) | 2006-05-31 |
| IL171607A (en) | 2016-05-31 |
| JP2011137042A (ja) | 2011-07-14 |
| JP4814086B2 (ja) | 2011-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0315319A (pt) | Terapias e procedimentos dentais com toxina botulìnica | |
| BR112022002599A2 (pt) | Vesícula extracelular ligada a moléculas e usos da mesma | |
| BRPI0415397A (pt) | métodos e reagentes para o tratamento de desordens imunoinflamatórias | |
| BRPI0512220A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
| MX2020003557A (es) | Terapias genicas para los trastornos lisosomales. | |
| IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
| BRPI0417493B8 (pt) | uso de uma toxina botulínica para tratamento de distúrbios da pele | |
| CR8380A (es) | Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos | |
| AR044007A1 (es) | Metodos para el tratamiento de la enfermedad de parkinson | |
| BR0111698A (pt) | Método para o tratamento de um distúrbio de movimento | |
| BR0013122A (pt) | Ciclobenzaprina para tratamento de distúrbio de ansiedade generalizado e composições de ciclobenzaprina | |
| BRPI0408236A (pt) | método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer | |
| BR0316906A (pt) | administração do capsaicinoides | |
| BRPI0612119A2 (pt) | tratamento de distúrbio auto-imunes com uma neuroxotina | |
| BRPI0607094A2 (pt) | composto da fórmula i; uso do composto para o tratamento de uma doença ou distúrbio associado à atividade excessiva de bace em um paciente que dele necessita; uso do composto para modular a atividade de bace; e composição farmacêutica | |
| BRPI0710485B8 (pt) | composições líquidas úteis no tratamento de doenças respiratórias | |
| BRPI0606902A2 (pt) | composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica | |
| BR0011823A (pt) | Derivado de benzimidazol, composto, composição farmacêutica, uso de um derivado de benzimidazol, e, método para tratamento, prevenção ou alìvio de uma doença ou de um distúrbio ou de uma condição de um corpo animal vivo | |
| BR0316685A (pt) | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade | |
| BR0014710A (pt) | Métodos para o tratamento de dor | |
| BR112023021131A2 (pt) | Tratamento de tremor essencial | |
| BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
| BRPI0607536A2 (pt) | tratamento de dor | |
| BRPI0415781A (pt) | método para o tratamento de diabetes em um paciente e kit farmacêutico | |
| BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 38/48 (2006.01), A61P 29/00 (2006.01), A61P 2 |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |